These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 25252784)

  • 1. Development of αGlcN(1↔1)αMan-based lipid A mimetics as a novel class of potent Toll-like receptor 4 agonists.
    Adanitsch F; Ittig S; Stöckl J; Oblak A; Haegman M; Jerala R; Beyaert R; Kosma P; Zamyatina A
    J Med Chem; 2014 Oct; 57(19):8056-71. PubMed ID: 25252784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-endotoxic activity and structural basis for human MD-2·TLR4 antagonism of tetraacylated lipid A mimetics based on βGlcN(1↔1)αGlcN scaffold.
    Garate JA; Stöckl J; Fernández-Alonso Mdel C; Artner D; Haegman M; Oostenbrink C; Jiménez-Barbero J; Beyaert R; Heine H; Kosma P; Zamyatina A
    Innate Immun; 2015 Jul; 21(5):490-503. PubMed ID: 25394365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tailored Modulation of Cellular Pro-inflammatory Responses With Disaccharide Lipid A Mimetics.
    Heine H; Adanitsch F; Peternelj TT; Haegman M; Kasper C; Ittig S; Beyaert R; Jerala R; Zamyatina A
    Front Immunol; 2021; 12():631797. PubMed ID: 33815382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformationally constrained lipid A mimetics for exploration of structural basis of TLR4/MD-2 activation by lipopolysaccharide.
    Artner D; Oblak A; Ittig S; Garate JA; Horvat S; Arrieumerlou C; Hofinger A; Oostenbrink C; Jerala R; Kosma P; Zamyatina A
    ACS Chem Biol; 2013 Nov; 8(11):2423-32. PubMed ID: 23952219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid A Mimetics Based on Unnatural Disaccharide Scaffold as Potent TLR4 Agonists for Prospective Immunotherapeutics and Adjuvants.
    Strobl S; Hofbauer K; Heine H; Zamyatina A
    Chemistry; 2022 Jun; 28(35):e202200547. PubMed ID: 35439332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Funiculosin variants and phosphorylated derivatives promote innate immune responses via the Toll-like receptor 4/myeloid differentiation factor-2 complex.
    Okamoto N; Mizote K; Honda H; Saeki A; Watanabe Y; Yamaguchi-Miyamoto T; Fukui R; Tanimura N; Motoi Y; Akashi-Takamura S; Kato T; Fujishita S; Kimura T; Ohto U; Shimizu T; Hirokawa T; Miyake K; Fukase K; Fujimoto Y; Nagai Y; Takatsu K
    J Biol Chem; 2017 Sep; 292(37):15378-15394. PubMed ID: 28754693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species and mediator specific TLR4 antagonism in primary human and murine immune cells by βGlcN(1↔1)αGlc based lipid A mimetics.
    Chebrolu C; Artner D; Sigmund AM; Buer J; Zamyatina A; Kirschning CJ
    Mol Immunol; 2015 Oct; 67(2 Pt B):636-41. PubMed ID: 26319313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential activation of human TLR4 by Escherichia coli and Shigella flexneri 2a lipopolysaccharide: combined effects of lipid A acylation state and TLR4 polymorphisms on signaling.
    Rallabhandi P; Awomoyi A; Thomas KE; Phalipon A; Fujimoto Y; Fukase K; Kusumoto S; Qureshi N; Sztein MB; Vogel SN
    J Immunol; 2008 Jan; 180(2):1139-47. PubMed ID: 18178854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of CD14 and TLR4·MD-2 activities by a synthetic lipid A mimetic.
    Cighetti R; Ciaramelli C; Sestito SE; Zanoni I; Kubik Ł; Ardá-Freire A; Calabrese V; Granucci F; Jerala R; Martín-Santamaría S; Jiménez-Barbero J; Peri F
    Chembiochem; 2014 Jan; 15(2):250-8. PubMed ID: 24339336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of c-Src: a hub for exogenous pro-oxidant-mediated activation of Toll-like receptor 4 signaling.
    Karki R; Zhang Y; Igwe OJ
    Free Radic Biol Med; 2014 Jun; 71():256-269. PubMed ID: 24637265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Toll-like receptors by Burkholderia pseudomallei.
    West TE; Ernst RK; Jansson-Hutson MJ; Skerrett SJ
    BMC Immunol; 2008 Aug; 9():46. PubMed ID: 18691413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the immunostimulatory potency of diethanolamine-containing lipid A mimics.
    Lewicky JD; Ulanova M; Jiang ZH
    Bioorg Med Chem; 2013 Apr; 21(8):2199-2209. PubMed ID: 23490149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationally Designed TLR4 Ligands for Vaccine Adjuvant Discovery.
    Gregg KA; Harberts E; Gardner FM; Pelletier MR; Cayatte C; Yu L; McCarthy MP; Marshall JD; Ernst RK
    mBio; 2017 May; 8(3):. PubMed ID: 28487429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
    Mishra V; Pathak C
    J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Human Toll-like Receptor 4 (TLR4)·Myeloid Differentiation Factor 2 (MD-2) by Hypoacylated Lipopolysaccharide from a Clinical Isolate of Burkholderia cenocepacia.
    Di Lorenzo F; Kubik Ł; Oblak A; Lorè NI; Cigana C; Lanzetta R; Parrilli M; Hamad MA; De Soyza A; Silipo A; Jerala R; Bragonzi A; Valvano MA; Martín-Santamaría S; Molinaro A
    J Biol Chem; 2015 Aug; 290(35):21305-19. PubMed ID: 26160169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetraacylated lipid A and paclitaxel-selective activation of TLR4/MD-2 conferred through hydrophobic interactions.
    Resman N; Oblak A; Gioannini TL; Weiss JP; Jerala R
    J Immunol; 2014 Feb; 192(4):1887-95. PubMed ID: 24420921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A synthetic lipid A mimetic modulates human TLR4 activity.
    Piazza M; Calabrese V; Damore G; Cighetti R; Gioannini T; Weiss J; Peri F
    ChemMedChem; 2012 Feb; 7(2):213-7. PubMed ID: 22140087
    [No Abstract]   [Full Text] [Related]  

  • 18. Structure-Based Design and Synthesis of Lipid A Derivatives to Modulate Cytokine Responses.
    Verpalen ECJM; Brouwer AJ; Wolfert MA; Boons GJ
    Chemistry; 2024 Jun; 30(32):e202400429. PubMed ID: 38587187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring Species-Specificity in TLR4/MD-2 Inhibition with Amphiphilic Lipid A Mimicking Glycolipids.
    Borio A; Holgado A; Passegger C; Strobl H; Beyaert R; Heine H; Zamyatina A
    Molecules; 2023 Aug; 28(16):. PubMed ID: 37630200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel synthetic acyclic lipid A-like agonist activates cells via the lipopolysaccharide/toll-like receptor 4 signaling pathway.
    Lien E; Chow JC; Hawkins LD; McGuinness PD; Miyake K; Espevik T; Gusovsky F; Golenbock DT
    J Biol Chem; 2001 Jan; 276(3):1873-80. PubMed ID: 11032843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.